Cite
HARVARD Citation
Highsmith, E. et al. (2021). Outcomes Associated With 4‐Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients. Journal of clinical pharmacology. pp. 598-605. [Online].